Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2885 SEK | -3.35% | -10.40% | -97.12% |
05-22 | Xbrane Successfully Scale Up Xdivane- Biosimilar Candidate to Opdivo®? | CI |
05-16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 |